Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001013594-25-001422·CytomX Therapeutics, Inc.
Schedule 13G ownership disclosure
CytomX Therapeutics Inc
Common Stock, $0.00001 par value per share · CUSIP: 23284F105
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Seven Fleet Master Fund LP
Shares: 48,898 · Class: 0.02%
- Seven Fleet Capital Management LP
Shares: 48,898 · Class: 0.02%
- Seven Fleet Capital Management GP LLC
Shares: 48,898 · Class: 0.02%
- Brian Liu
Shares: 48,898 · Class: 0.02%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013594-25-001422
- Form type
- SCHEDULE 13G/A
- Filer
- CytomX Therapeutics, Inc.
- CIK
- CIK 1501989
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership